MicroRNA-150 predicts a favorable prognosis in patients with epithelial ovarian cancer, and inhibits cell invasion and metastasis by suppressing transcriptional repressor ZEB1

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Jin, Minfei ^a   Yang, Zujing ^a   Ye, Weiping ^a   Xu, Hongling ^a   Hua, Xiaolin ^a  

^a XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 150; TRANSCRIPTION FACTOR ZEB1; UNCLASSIFIED DRUG; HOMEODOMAIN PROTEIN; MESSENGER RNA; MIRN150 MICRORNA, HUMAN; REPRESSOR PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; ZEB1 PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER GRADING; CANCER INHIBITION; CANCER PATIENT; CANCER PROGNOSIS; CANCER TISSUE; CARCINOGENESIS; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUCIFERASE ASSAY; OVARY CARCINOMA; OVARY METASTASIS; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TUMOR GROWTH; TUMOR INVASION; DISEASE COURSE; DISEASE FREE SURVIVAL; GENE EXPRESSION REGULATION; GENETICS; KAPLAN MEIER METHOD; METABOLISM; METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM; OVARY TUMOR; PATHOLOGY; PROGNOSIS; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; KAPLAN-MEIER ESTIMATE; MICRORNAS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REPRESSOR PROTEINS; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS;

EID: 84905493043     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103965     Document Type: Article

References (32)

1. Foley OW, Rauh-Hain JA, del Carmen MG (2013) Recurrent epithelial ovarian cancer: an update on treatment. Oncology (Williston Park). 27: 288-94, 298.
2. Xu L, Cai J, Yang Q, Ding H, Wu L, et al (2013) Prognostic significance of several biomarkers in epithelial ovarian cancer: a meta-analysis of published studies. J Cancer Res Clin Oncol. 139: 1257-77.
3. Coleman RL, Monk BJ, Sood AK, Herzog TJ (2013) Latest research and treatment of advanced-stage epithelial ovarian cancer. Nat Rev Clin Oncol. 10: 211-24.
4. Minig L, Otano L, Diaz-Padilla I, Alvarez Gallego R, Patrono MG, et al (2013) Therapeutic management of epithelial ovarian cancer during pregnancy. Clin Transl Oncol. 15: 259-64.
5. Farazi TA, Hoell JI, Morozov P, Tuschl T (2013) MicroRNAs in human cancer. Adv Exp Med Biol 774: 1-20.
6. Zaman MS, Maher DM, Khan S, Jaggi M, Chauhan SC (2012) Current status and implications of microRNAs in ovarian cancer diagnosis and therapy. Journal of ovarian research 5: 44.
7. Yeh YM, Chuang CM, Chao KC, Wang LH (2013) MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis by targeting SOX4 and HIF-1 a. Int J Cancer. 133: 867-78.
8. Wang YQ, Guo RD, Guo RM, Sheng W, Yin LR (2013) MicroRNA-182 promotes cell growth, invasion, and chemoresistance by targeting programmed cell death 4 (PDCD4) in human ovarian carcinomas. J Cell Biochem. 114: 1464-73.
9. Wu H, Xiao Z, Wang K, Liu W, Hao Q (2013) MiR-145 is downregulated in human ovarian cancer and modulates cell growth and invasion by targeting p70S6K1 and MUC1. Biochem Biophys Res Commun. 441: 693-700.
10. Mraz M, Chen L, Rassenti LZ, Ghia EM, Li H, et al (2014) MicroRNA-150 contributes to the proficiency of B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1 genes. Blood. In press.
11. Gebauer N, Kuba J, Senft A, Schillert A, Bernard V, et al (2014) MicroRNA-150 Is up-regulated in extranodal marginal zone lymphoma of MALT type. Cancer Genomics Proteomics. 11: 51-6.
12. Wang M, Yang W, Li M, Li Y (2014) Low expression of miR-150 in pediatric intestinal Burkitt lymphoma. Exp Mol Pathol. 96: 261-6.
13. Gu XY, Wang J, Luo YZ, Du Q, Li RR, et al (2014) Down-regulation of miR-150 induces cell proliferation inhibition and apoptosis in non-small-cell lung cancer by targeting BAK1 in vitro. Tumor Biol. In press.
14. Vang S, Wu HT, Fischer A, Miller DH, MacLaughlan S, et al (2013) Identification of ovarian cancer metastatic miRNAs. PLoS One. 8: e58226.
15. Shapira I, Oswald M, Lovecchio J, Khalili H, Menzin A, et al (2014) Circulating biomarkers for detection of ovarian cancer and predicting cancer outcomes. Br J Cancer. 110: 976-83.
16. Srivastava SK, Bhardwaj A, Singh S, Arora S, Wang B, et al (2011) MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells. Carcinogenesis. 32: 1832-9.
17. Hsu SD, Tseng YT, Shrestha S, Lin YL, Khaleel A, et al (2014) miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions. Nucleic Acids Res. 42 (Database issue): D78-85.
18. Hsu SD, Lin FM, Wu WY, Liang C, Huang WC, et al (2011) miRTarBase: a database curates experimentally validated microRNA-target interactions. Nucleic Acids Res. 39 (Database issue): D163-9.
19. Krüger J, Rehmsmeier M (2006) RNAhybrid: microRNA target prediction easy, fast and flexible. Nucleic Acids Res. 34 (Web Server issue): W451-4.
20. Wu Q, Jin H, Yang Z, Luo G, Lu Y, et al (2010) MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2. Biochem Biophys Res Commun. 392: 340-5.
21. Ito M, Teshima K, Ikeda S, Kitadate A, Watanabe A, et al (2014) MicroRNA-150 inhibits tumor invasion and metastasis by targeting the chemokine receptor CCR6, in advanced cutaneous T-cell lymphoma. Blood. 123: 1499-511.
22. Watanabe A, Tagawa H, Yamashita J, Teshima K, Nara M, et al (2011) The role of microRNA-150 as a tumor suppressor in malignant lymphoma. Leukemia. 25: 1324-34.
23. Yokobori T, Suzuki S, Tanaka N, Inose T, Sohda M, et al (2013) MiR-150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducer ZEB1. Cancer Sci. 104: 48-54.
24. Luo Z, Wen G, Wang G, Pu X, Ye S, et al (2013) MicroRNA-200C and -150 play an important role in endothelial cell differentiation and vasculogenesis by targeting transcription repressor ZEB1. Stem Cells. 31: 1749-62.
25. Quan Y, Jin R, Huang A, Zhao H, Feng B, et al (2014) Downregulation of GRHL2 inhibits the proliferation of colorectal cancer cells by targeting ZEB1. Cancer Biol Ther. In press.
26. Liu Y, Sánchez-Tilló E, Lu X, Huang L, Clem B, et al (2014) The ZEB1 transcription factor acts in a negative feedback loop with miR200 downstream of Ras and Rb1 to regulate Bmi1 expression. J Biol Chem. 289: 4116-25.
27. Roche J, Nasarre P, Gemmill R, Baldys A, Pontis J, et al (2013) Global Decrease of Histone H3K27 Acetylation in ZEB1-Induced Epithelial to Mesenchymal Transition in Lung Cancer Cells. Cancers (Basel). 5: 334-56.
28. Chen Z, Li S, Huang K, Zhang Q, Wang J, et al (2013) The nuclear protein expression levels of SNAI1 and ZEB1 are involved in the progression and lymph node metastasis of cervical cancer via the epithelial-mesenchymal transition pathway. Hum Pathol. 44: 2097-105.
29. Yang Y, Ahn YH, Chen Y, Tan X, Guo L, et al (2014) ZEB1 sensitizes lung adenocarcinoma to metastasis suppression by PI3K antagonism. J Clin Invest. In press.
30. Lobert S, Graichen ME, Morris K (2013) Coordinated regulation of β-tubulin isotypes and epithelial-to-mesenchymal transition protein ZEB1 in breast cancer cells. Biochemistry. 52: 5482-90.
31. Zhang GJ, Zhou T, Tian HP, Liu ZL, Xia SS (2013) High expression of ZEB1 correlates with liver metastasis and poor prognosis in colorectal cancer. Oncol Lett. 5: 564-568.
32. Chen D, Wang J, Zhang Y, Chen J, Yang C, et al (2013) Effect of downregulated transcriptional repressor ZEB1 on the epithelial-mesenchymal transition of ovarian cancer cells. Int J Gynecol Cancer. 23: 1357-66.